<code id='F6A5B5BD79'></code><style id='F6A5B5BD79'></style>
    • <acronym id='F6A5B5BD79'></acronym>
      <center id='F6A5B5BD79'><center id='F6A5B5BD79'><tfoot id='F6A5B5BD79'></tfoot></center><abbr id='F6A5B5BD79'><dir id='F6A5B5BD79'><tfoot id='F6A5B5BD79'></tfoot><noframes id='F6A5B5BD79'>

    • <optgroup id='F6A5B5BD79'><strike id='F6A5B5BD79'><sup id='F6A5B5BD79'></sup></strike><code id='F6A5B5BD79'></code></optgroup>
        1. <b id='F6A5B5BD79'><label id='F6A5B5BD79'><select id='F6A5B5BD79'><dt id='F6A5B5BD79'><span id='F6A5B5BD79'></span></dt></select></label></b><u id='F6A5B5BD79'></u>
          <i id='F6A5B5BD79'><strike id='F6A5B5BD79'><tt id='F6A5B5BD79'><pre id='F6A5B5BD79'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:22854
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Roche’s Alnylam deal shows drug firms interested in heart drugs
          Roche’s Alnylam deal shows drug firms interested in heart drugs

          AdobeRoche’sannouncementMondaythatitwouldpay$310millionforrightstoahypertensiontreatment,zilebesiran

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Why medical students are struggling with mental health

          Forthemanyhigh-achievingperfectionistswhoentermedicalschooleachyear,thestakesoftheirsuccesshavenever